Paige, a NYC-based computational pathology company, received an additional $15M from Goldman Sachs Merchant Banking Division.
The funding will be added to previously announced Series B financing, bringing the total round to $70M, including an additional investment from Healthcare Venture Partners of $5M on top of their previous $10M investment.
Paige will use this new capital to further accelerate its global leadership position in transforming pathology workflows in the field of cancer, while working closely with biopharma companies to create custom diagnostic and clinical trial solutions to improve patient care.
Led by Leo Grady, Ph.D., CEO, Paige Founded in 2017 by Thomas Fuchs, Dr.Sc., and colleagues from Memorial Sloan Kettering Cancer Center, Paige builds computational pathology products for care teams to make informed treatment decisions.
FinSMEs
13/07/2020